Released on: December 6, 2007, 1:06 am

Press Release Author: Shushmul Maheshwari

Industry:

Press Release Summary: India is fast emerging as the favorable outsourcing
destination globally for clinical trial and clinical data management due to the
plethora of advantages it offers, including naïve patient population, better
infrastructure, and lucrative pharma market.

Press Release Body: The world’s one of the biggest emerging powers, India, is
showing its presence in the field of clinical trials also. In recent times, the
country has provided the favorable platform for conducting clinical trials and thus,
is working for several international companies. Sensing the importance of India as a
clinical trial hub, the leading market research firm RNCOS has launched its report
“Booming Clinical Trials Market in India” to give first-hand information
on the Indian clinical trials market.

What make India a preferred destination globally to outsource clinical trials are
its naïve patient populace, skilled medical professionals, attractive pharmaceutical
market, industry-supportive regulations, and advanced technological infrastructure.
Due to these promoters, Indian clinical trials market is projected to swell at a
CAGR of around 35.5% from 2006 to 2011.

India is also fast becoming a hotspot for clinical data management. The RNCOS
research says that as India has a pool of skilled manpower with required IT
expertise, therefore, it scores high over any other country for the outsourcing of
clinical trial data management. Moreover, as India offers best clinical data
management services at low cost, most of the US- and Europe-based multinational
pharmaceutical companies are focusing on it.

But the biggest advantage of India is its large patient pool which can be recruited
in much shorter time than its western counterparts, highlights the research.
Recognizing the need of the hour, all leading Clinical Research Organizations (CROs)
and pharmaceutical companies have already banged on with their clinical trials in
India.

The Indian clinical trial industry is certainly in growth phase but to exploit its
full potential and achieve seamless growth, the country needs to tackle issues like
delay in trial approval process, lack of GCP (Good Clinical Practice)-certified
investigators and site, and improper protection of clinical data, says the report.

“Booming Clinical Trials Market in India” gives comprehensive
information on the current landscape of clinical trials in India. It thoroughly
discusses the factors that are making India a favorable destination for clinical
trial outsourcing together with regulatory environment and economic analysis of
clinical trial phases. It chalks out the opportunity areas and challenges for the
market and based on all these, augurs the future course of direction of the market.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM564.htm
Current Industry News: http://www.rncos.com/blog


Web Site: http://www.rncos.com

Contact Details: RNCOS E-Services Pvt Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com